128 related articles for article (PubMed ID: 22120847)
21. Applications of lentiviral vectors for shRNA delivery and transgenesis.
Singer O; Verma IM
Curr Gene Ther; 2008 Dec; 8(6):483-8. PubMed ID: 19075631
[TBL] [Abstract][Full Text] [Related]
22. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
[TBL] [Abstract][Full Text] [Related]
23. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
Kasumu A; Bezprozvanny I
Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
[TBL] [Abstract][Full Text] [Related]
24. Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter.
Takayama K; Torashima T; Horiuchi H; Hirai H
Neurosci Lett; 2008 Sep; 443(1):7-11. PubMed ID: 18675313
[TBL] [Abstract][Full Text] [Related]
25. Global Knockdown of Retinoid-related Orphan Receptor α in Mature Purkinje Cells Reveals Aberrant Cerebellar Phenotypes of Spinocerebellar Ataxia.
Yasui H; Matsuzaki Y; Konno A; Hirai H
Neuroscience; 2021 May; 462():328-336. PubMed ID: 32278059
[TBL] [Abstract][Full Text] [Related]
26. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
Kong J; Kim SR; Binley K; Pata I; Doi K; Mannik J; Zernant-Rajang J; Kan O; Iqball S; Naylor S; Sparrow JR; Gouras P; Allikmets R
Gene Ther; 2008 Oct; 15(19):1311-20. PubMed ID: 18463687
[TBL] [Abstract][Full Text] [Related]
27. A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCγ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior.
Shimobayashi E; Kapfhammer JP
J Neurosci; 2021 Mar; 41(9):2053-2068. PubMed ID: 33478986
[TBL] [Abstract][Full Text] [Related]
28. Advances in lentiviral vectors: a patent review.
Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells.
Chang YK; Chen MH; Chiang YH; Chen YF; Ma WH; Tseng CY; Soong BW; Ho JH; Lee OK
J Biomed Sci; 2011 Aug; 18(1):54. PubMed ID: 21824437
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
31. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors.
Alisky JM; Hughes SM; Sauter SL; Jolly D; Dubensky TW; Staber PD; Chiorini JA; Davidson BL
Neuroreport; 2000 Aug; 11(12):2669-73. PubMed ID: 10976941
[TBL] [Abstract][Full Text] [Related]
32. Toward integrase defective lentiviral vectors for genetic immunization.
Negri DR; Michelini Z; Cara A
Curr HIV Res; 2010 Jun; 8(4):274-81. PubMed ID: 20353396
[TBL] [Abstract][Full Text] [Related]
33. Production of lentiviral vectors for transducing cells from the central nervous system.
Li M; Husic N; Lin Y; Snider BJ
J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.
Chopra R; Wasserman AH; Pulst SM; De Zeeuw CI; Shakkottai VG
Hum Mol Genet; 2018 Apr; 27(8):1396-1410. PubMed ID: 29432535
[TBL] [Abstract][Full Text] [Related]
35. Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST.
Perkins EM; Suminaite D; Clarkson YL; Lee SK; Lyndon AR; Rothstein JD; Wyllie DJ; Tanaka K; Jackson M
Hum Mol Genet; 2016 Oct; 25(20):4448-4461. PubMed ID: 28173092
[TBL] [Abstract][Full Text] [Related]
36. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
[TBL] [Abstract][Full Text] [Related]
37. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
[TBL] [Abstract][Full Text] [Related]
38. Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases.
Shiba K; Torashima T; Hirai H; Ogawa K; Akhter N; Nakajima K; Kinuya S; Mori H
J Cereb Blood Flow Metab; 2009 Feb; 29(2):434-40. PubMed ID: 19002197
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral transgenesis--a versatile tool for basic research and gene therapy.
Pfeifer A
Curr Gene Ther; 2006 Aug; 6(4):535-42. PubMed ID: 16918338
[TBL] [Abstract][Full Text] [Related]
40. Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K.
Goenawan H; Hirai H
J Neurovirol; 2012 Dec; 18(6):521-31. PubMed ID: 23070819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
